Production (Stage)
Zomedica Corp.
ZOMDF
$0.047
-$0.0022-4.47%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.80% | 7.61% | 10.24% | 1.84% | 14.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.80% | 7.61% | 10.24% | 1.84% | 14.23% |
| Cost of Revenue | -2.42% | 3.67% | -2.42% | -10.29% | 30.24% |
| Gross Profit | 7.04% | 9.36% | 16.00% | 7.76% | 7.35% |
| SG&A Expenses | -11.49% | -13.48% | 12.83% | 19.82% | 22.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.61% | -14.26% | 17.42% | 18.90% | 28.12% |
| Operating Income | 16.09% | 28.35% | -25.08% | -34.13% | -38.26% |
| Income Before Tax | -584.82% | 66.21% | -178.89% | -352.01% | -50.98% |
| Income Tax Expenses | 65.66% | -148.15% | 98.59% | -85.71% | -179.81% |
| Earnings from Continuing Operations | -596.60% | 67.89% | -1,263.95% | -355.92% | -43.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -596.60% | 67.89% | -1,263.95% | -355.92% | -43.46% |
| EBIT | 16.09% | 28.35% | -25.08% | -34.13% | -38.26% |
| EBITDA | 23.11% | 35.81% | -24.36% | -34.00% | -37.50% |
| EPS Basic | -600.00% | 68.12% | -1,260.00% | -351.85% | -43.08% |
| Normalized Basic EPS | 15.00% | 28.79% | -44.83% | -50.00% | -53.85% |
| EPS Diluted | -600.00% | 27.07% | -1,260.00% | -351.85% | -53.85% |
| Normalized Diluted EPS | 15.00% | 28.79% | -44.83% | -50.00% | -53.85% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |